Regal One

Regal One Corporation was a publicly traded business development company (BDC) that specialized in the biotechnology and life sciences sectors during the early to mid-2000s. The company's primary business model involved identifying, mentoring, and restructuring early-stage biomedical firms to prepare them for public listings or other liquidity events. Its most notable transaction was the 2006 restructuring and public launch of Neuralstem, Inc., a pioneer in human neural stem cell technology for treating central nervous system disorders. Regal One also maintained strategic investments in other regenerative medicine entities, such as American Stem Cell Corp. Headquartered in Las Vegas, the company provided capital and strategic guidance to firms developing next-generation medical technologies before eventually becoming inactive in the public markets.